• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.

作者信息

Cross A J, Slater P, Simpson M, Royston C, Deakin J F, Perry R H, Perry E K

机构信息

Astra Neuroscience Research Unit, London, U.K.

出版信息

Neurosci Lett. 1987 Aug 18;79(1-2):213-7. doi: 10.1016/0304-3940(87)90699-9.

DOI:10.1016/0304-3940(87)90699-9
PMID:2823192
Abstract

The sodium dependent binding of D-[3H]aspartate to the high-affinity glutamate uptake system was used as a marker of glutamate-releasing terminals in the cerebral cortex of brains from patients with Alzheimer-type dementia (ATD) and Parkinson's disease (PD). Sodium-dependent D-[3H]aspartate binding was reduced in the ATD patients but not in the PD patients. Within the PD patients no association was observed between sodium-dependent D-[3H]aspartate binding and the presence of dementia. In contrast choline acetyltransferase activity was reduced in both the ATD and the PD patients. The present results suggest that changes in the cortical cholinergic system can occur independently of the cortical glutamate system. The glutamatergic deficit in ATD may contribute to some of the clinical differences between the dementia of ATD and PD.

摘要

相似文献

1
Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
Neurosci Lett. 1987 Aug 18;79(1-2):213-7. doi: 10.1016/0304-3940(87)90699-9.
2
Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.阿尔茨海默型老年痴呆症中皮质谷氨酸能结合位点的差异性改变。
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1352-6. doi: 10.1073/pnas.87.4.1352.
3
Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.阿尔茨海默病中突触前和突触后谷氨酸能功能的区域分布
Brain Res. 1988 Jun 14;452(1-2):403-7. doi: 10.1016/0006-8993(88)90048-0.
4
Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brains.阿尔茨海默病大脑中[3H]D-天冬氨酸和[3H]TCP结合位点的区域变化。
Brain Res. 1988 Oct 11;462(1):76-82. doi: 10.1016/0006-8993(88)90587-2.
5
Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.阿尔茨海默病、帕金森病患者以及基底前脑损伤大鼠颞叶皮质中的胆碱乙酰转移酶活性和[3H]维司米醇结合
Neuroscience. 1990;35(2):327-33. doi: 10.1016/0306-4522(90)90086-j.
6
Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.阿尔茨海默病和帕金森病的皮质神经病理学及神经化学基础。
J Neural Transm Suppl. 1987;24:131-6.
7
Reduced D-[3H]aspartate binding in Down's syndrome brains.唐氏综合征患者大脑中D-[3H]天冬氨酸结合减少。
Brain Res. 1989 Apr 10;484(1-2):273-8. doi: 10.1016/0006-8993(89)90370-3.
8
Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.阿尔茨海默病中突触前和突触后谷氨酸能功能
Neurosci Lett. 1988 Mar 21;86(1):109-13. doi: 10.1016/0304-3940(88)90192-9.
9
Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.阿尔茨海默病和亨廷顿病中L-谷氨酸结合的改变。
Science. 1985 Mar 22;227(4693):1496-9. doi: 10.1126/science.2858129.
10
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.阿尔茨海默病和帕金森病中烟碱型和毒蕈碱型结合位点的比较性改变。
J Neurochem. 1992 Feb;58(2):529-41. doi: 10.1111/j.1471-4159.1992.tb09752.x.

引用本文的文献

1
The glutamatergic system in Alzheimer's disease: a systematic review with meta-analysis.阿尔茨海默病中的谷氨酸能系统:系统评价与荟萃分析。
Mol Psychiatry. 2024 Jul;29(7):2261-2273. doi: 10.1038/s41380-024-02473-0. Epub 2024 Feb 16.
2
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease.胆碱能、肾上腺素能和谷氨酸能网络调节与阿尔茨海默病认知功能障碍的关系。
Int J Mol Sci. 2021 Feb 25;22(5):2283. doi: 10.3390/ijms22052283.
3
4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures.
4-羟基己醛(HHE)可损害星形胶质细胞培养物中的谷氨酸转运。
J Alzheimers Dis. 2012;32(1):139-46. doi: 10.3233/JAD-2012-120409.
4
Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.阿尔茨海默病皮质中淀粉样β优先积聚在突触前谷氨酸能末梢(VGluT1 和 VGluT2)。
Neurobiol Dis. 2012 Jan;45(1):381-7. doi: 10.1016/j.nbd.2011.08.027. Epub 2011 Sep 3.
5
Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.胆固醇 24S-羟化酶表达增加导致神经胶质谷氨酸转运体 EAAT2 与脂筏解偶联:阿尔茨海默病潜在作用机制。
J Neurochem. 2010 May;113(4):978-89. doi: 10.1111/j.1471-4159.2010.06661.x. Epub 2010 Feb 27.
6
Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia.星形胶质细胞中兴奋性氨基酸转运体2(EAAT2)的选择性过表达增强了对中度而非重度缺氧缺血的神经保护作用。
Neuroscience. 2008 Sep 9;155(4):1204-11. doi: 10.1016/j.neuroscience.2008.05.059. Epub 2008 Jun 17.
7
Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment.轻度认知障碍期间谷氨酸能突触前终扣的反常上调
J Neurosci. 2007 Oct 3;27(40):10810-7. doi: 10.1523/JNEUROSCI.3269-07.2007.